# A Drug Interaction Study Assess the Effects of ZSP1273 Tablets on the Pharmacokinetics of Warfarin and Midazolam

> **NCT05942365** · PHASE1 · COMPLETED · sponsor: **Guangdong Raynovent Biotech Co., Ltd** · enrollment: 28 (actual)

## Conditions studied

- Drug Drug Interaction
- Warfarin
- Midazolam

## Interventions

- **DRUG:** ZSP1273

## Key facts

- **NCT ID:** NCT05942365
- **Lead sponsor:** Guangdong Raynovent Biotech Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-25
- **Primary completion:** 2023-07-21
- **Final completion:** 2023-08-04
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2023-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05942365

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05942365, "A Drug Interaction Study Assess the Effects of ZSP1273 Tablets on the Pharmacokinetics of Warfarin and Midazolam". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05942365. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*